MedPath

GABAPENTIN

GABAPENTIN

Discontinued
DIN Number

02238673

Drug Class

Human

Market Date

N/A

Company
HC

omni laboratories division, warner-lambert canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238673
AIG Number0125929002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF01 GABAPENTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

GABAPENTINActive
Strength: 400 MG / CAP
Monograph: GABAPENTIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.